All fact checks
AI analysis
Fact check
“The FDA is seeking comments, data, and information from the public on protocol elements relevant to ibogaine development, including dose selection and escalation, care setting, safety monitoring, eligibility criteria, stopping rules, and safety oversight.”
UnverifiableConfidence: LOW
Reasoning
The claim states that the FDA is seeking public input on specific protocol elements for ibogaine development. Without any provided documents, statements, or references from the FDA or related sources, there is no basis to verify the accuracy of this assertion.
On confidence: No evidence was supplied to confirm or refute the claim.
Evidence
No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.
Limitations
The assessment is limited to the absence of supplied evidence; external verification was not performed.
- Last verified:
- Oct 6, 2026, 4:16 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for InformationFederal Register · Drug Administration, Human Services Department, Food, Health